Limited community awareness, late and superficial institutional support, and cost-effectiveness issues paint a bleak future for Pre-Exposure Prophylaxis in the UK. On the opening day of the TasP PrEP Evidence Summit organised by IAPAC, Lord Fowler expressed his bemusement at the US attitude towards clean
The TasP PrEP evidence Summit organised by the International Association of Providers of AIDS Care (IAPAC) opens in London with a welcomed tone that departs from the usual HIV Grand Masses. There is something in the annual IAPAC conference in London that is not often
Don’t we all know that popping pills is not the solution to all our problems? The writer reflects on his and other’s assumptions about the role of biomedical interventions in the control of the HIV epidemic. This blog’s title mirrors that of Jake Sobo’s “Why
Pre-Exposure Prophylaxis (PrEP) study demonstrates effectiveness of ARV for preventing HIV acquisition in IDU but emphasises quandary with clinical benefit realisation. The Bangkok Tenofovir study published in The Lancet was conducted by the US CDC, the Bangkok Metropolitan Administration and the Thailand Ministry of Public
Today saw the launch of a new HIV prevention campaign in England by the Terrence Higgins Trust. The premise is bold: England “can halt HIV within a generation”. The campaign is based on an over-arching message that is simple: test regularly, treat, use condoms (and